Cover image for Quarterly Drug Pipeline: April 2025 Clinical insights and competitive intelligence on anticipated drugs in development Prime Therapeutics /quarterly-drug-pipeline-april-2025 Prime...

Cover image for Quarterly Drug Pipeline: July 2025 Clinical insights and competitive intelligence on anticipated drugs in development Prime Therapeutics /quarterly-drug-pipeline-july-2025 Prime...

Prime to present seven studies and receive the 2024 JMCP Award for Excellence

Prime Therapeutics researchers share more about award-winning real-world research

*Orphan drug status intravenous (IV); Prescription Drug User Fee Act (PDUFA) Cell therapy: Aims to replace or repair damaged cells through transplantation of healthy ones Editorial team Editor's...

Editor's message Editorial team Cell therapy= Transplantation of healthy cells to replace or repair damaged ones *Orphan drug status PDUFA= Prescription Drug User Fee Act IV= intravenous...

Specialty Pharmacy Continuum

Managed Healthcare Executive